Cytokines, namely, IL‐1β, TNF‐α, IL‐6 and IFN‐γ, rise 24 h post ischemia in a tMCAO model, and reducing the concentrations of these cytokines are highly advantageous to IS treatment. The gene discussed is IL6; the disease is ischemia.